WHO ICTRP trial

This study is to evaluate the effect of distillate of beetle leaf in acute…

CTRI/2020/01/022902 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2020/01/022902
Public title This study is to evaluate the effect of distillate of beetle leaf in acute exacerbation of bronchial asthma in children of 6 to 12 years
Scientific title CLINICAL STUDY ON THE EFFICACY OF TAMBOOLA ARKA IN ACUTE EPISODE OF TAMAKA SWASA(BRONCHIAL ASTHMA) IN CHILDREN
Primary sponsor Dr Nagendra Parsad Patel
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries India
Conditions Health Condition 1: J069- Acute upper respiratory infection,unspecified
Interventions Intervention1: Tambula arka: 3ml of tambula arka is given in the form of nebulisation every 4th hourly and 3.5 ml of oral dosage every 4th hourly for 6-9 years and 4.5 ml of oral dose every 4th hourly for 9-12 years Control Intervention1…
Registration date Jan 21, 2020
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations